Agios Pharmaceuticals appoints Jacqualyn Fouse to board
Dr. Fouse previously served as president and chief operating officer of Celgene Corporation until April 2017, and as a member of Celgene's board of directors through June 2017.
Dr. Fouse joined Celgene in 2010 as chief financial officer and was named president of the company's global hematology & oncology franchise in 2014.
Before joining Celgene, she served as chief financial officer of Bunge Limited.
Prior to Bunge, Dr. Fouse served as senior vice president, chief financial officer, and head of corporate strategy at Alcon Laboratoriesy.
Prior to her tenure with Alcon, she held a variety of senior leadership roles with international companies, spending almost a decade of her career in Switzerland.
Dr. Fouse earned her B.A. and M.A. in economics and a Ph.D. in finance from the University of Texas at Arlington.